Global Cefepime Market Growth 2020-2025
Apr, 2020
|
Report ID: 122024
|
178
|
Pharmaceuticals and Healthcare
According to this study, over the next five years the Cefepime market will register a xx% CAGR in terms of revenue, the global market size will reach $ xx million by 2025, from $ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Cefepime business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Cefepime market by type, application, key manufacturers and key regions and countries.
This study considers the Cefepime value and volume generated from the sales of the following segments:
Segmentation by type: breakdown data from 2015 to 2020, in Section 2.3; and forecast to 2025 in section 11.7.
Intramuscular Injection
Intravenous Drug Delivery
Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2024 in section 11.8.
Lower Respiratory Tract Infection
Urinary Tract Infection
Skin And Soft Tissue Infections
Abdominal Cavity Infection
Gynecologic Infection
Sepsis
Neutrophilic Fever
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Baxter
BMS
Apotex
Pfizer
Perrigo
B. Braun Medical
Piramal Critical Care
Fresenius Kabi
Meitheal Pharmaceuticals
Sandoz (Novartis)
Shandong Luoxin Pharmaceutical Group
Yuekang Pharmaceutical Group
Guangzhou Baiyunshan Tianxin Pharmaceutical
Qilu Pharmaceutical
Hebei Huamin Pharmaceutical
Shanghai Xinfeng Pharmaceutical
Jiangsu Hengrui Pharmaceutical
Nanjing Haichen Pharmaceutical
Sinopharm
Chengdu Beite Pharmaceutical
Suzhou Dongrui Pharmaceutical
Hainan Hailing Pharmaceutical
Shenzhen Xinlitai Pharmaceutical
Hainan Star Pharmaceutical
Shenzhen Lijian Pharmaceutical
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Cefepime consumption (value & volume) by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.
To understand the structure of Cefepime market by identifying its various subsegments.
Focuses on the key global Cefepime manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Cefepime with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Cefepime submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
This report presents a comprehensive overview, market shares, and growth opportunities of Cefepime market by type, application, key manufacturers and key regions and countries.
This study considers the Cefepime value and volume generated from the sales of the following segments:
Segmentation by type: breakdown data from 2015 to 2020, in Section 2.3; and forecast to 2025 in section 11.7.
Intramuscular Injection
Intravenous Drug Delivery
Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2024 in section 11.8.
Lower Respiratory Tract Infection
Urinary Tract Infection
Skin And Soft Tissue Infections
Abdominal Cavity Infection
Gynecologic Infection
Sepsis
Neutrophilic Fever
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Baxter
BMS
Apotex
Pfizer
Perrigo
B. Braun Medical
Piramal Critical Care
Fresenius Kabi
Meitheal Pharmaceuticals
Sandoz (Novartis)
Shandong Luoxin Pharmaceutical Group
Yuekang Pharmaceutical Group
Guangzhou Baiyunshan Tianxin Pharmaceutical
Qilu Pharmaceutical
Hebei Huamin Pharmaceutical
Shanghai Xinfeng Pharmaceutical
Jiangsu Hengrui Pharmaceutical
Nanjing Haichen Pharmaceutical
Sinopharm
Chengdu Beite Pharmaceutical
Suzhou Dongrui Pharmaceutical
Hainan Hailing Pharmaceutical
Shenzhen Xinlitai Pharmaceutical
Hainan Star Pharmaceutical
Shenzhen Lijian Pharmaceutical
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Cefepime consumption (value & volume) by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.
To understand the structure of Cefepime market by identifying its various subsegments.
Focuses on the key global Cefepime manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Cefepime with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Cefepime submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
Frequently Asked Questions
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
- By Type
- By Application
- By Region
- By Country
- By Manufacturer
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Cefepime Consumption 2015-2025
2.1.2 Cefepime Consumption CAGR by Region
2.2 Cefepime Segment by Type
2.2.1 Intramuscular Injection
2.2.2 Intravenous Drug Delivery
2.3 Cefepime Consumption by Type
2.3.1 Global Cefepime Consumption Market Share by Type (2015-2020)
2.3.2 Global Cefepime Revenue and Market Share by Type (2015-2020)
2.3.3 Global Cefepime Sale Price by Type (2015-2020)
2.4 Cefepime Segment by Application
2.4.1 Lower Respiratory Tract Infection
2.4.2 Urinary Tract Infection
2.4.3 Skin And Soft Tissue Infections
2.4.4 Abdominal Cavity Infection
2.4.5 Gynecologic Infection
2.4.6 Sepsis
2.4.7 Neutrophilic Fever
2.5 Cefepime Consumption by Application
2.5.1 Global Cefepime Consumption Market Share by Type (2015-2020)
2.5.2 Global Cefepime Value and Market Share by Type (2015-2020)
2.5.3 Global Cefepime Sale Price by Type (2015-2020)
3 Global Cefepime by Company
3.1 Global Cefepime Sales Market Share by Company
3.1.1 Global Cefepime Sales by Company (2018-2020)
3.1.2 Global Cefepime Sales Market Share by Company (2018-2020)
3.2 Global Cefepime Revenue Market Share by Company
3.2.1 Global Cefepime Revenue by Company (2018-2020)
3.2.2 Global Cefepime Revenue Market Share by Company (2018-2020)
3.3 Global Cefepime Sale Price by Company
3.4 Global Cefepime Manufacturing Base Distribution, Sales Area, Type by Company
3.4.1 Global Cefepime Manufacturing Base Distribution and Sales Area by Company
3.4.2 Players Cefepime Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 Cefepime by Regions
4.1 Cefepime by Regions
4.2 Americas Cefepime Consumption Growth
4.3 APAC Cefepime Consumption Growth
4.4 Europe Cefepime Consumption Growth
4.5 Middle East & Africa Cefepime Consumption Growth
5 Americas
5.1 Americas Cefepime Consumption by Countries
5.1.1 Americas Cefepime Consumption by Countries (2015-2020)
5.1.2 Americas Cefepime Value by Countries (2015-2020)
5.2 Americas Cefepime Consumption by Type
5.3 Americas Cefepime Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
5.8 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC Cefepime Consumption by Regions
6.1.1 APAC Cefepime Consumption by Regions (2015-2020)
6.1.2 APAC Cefepime Value by Regions (2015-2020)
6.2 APAC Cefepime Consumption by Type
6.3 APAC Cefepime Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions
7 Europe
7.1 Europe Cefepime by Countries
7.1.1 Europe Cefepime Consumption by Countries (2015-2020)
7.1.2 Europe Cefepime Value by Countries (2015-2020)
7.2 Europe Cefepime Consumption by Type
7.3 Europe Cefepime Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
8.1 Middle East & Africa Cefepime by Countries
8.1.1 Middle East & Africa Cefepime Consumption by Countries (2015-2020)
8.1.2 Middle East & Africa Cefepime Value by Countries (2015-2020)
8.2 Middle East & Africa Cefepime Consumption by Type
8.3 Middle East & Africa Cefepime Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Cefepime Distributors
10.3 Cefepime Customer
11 Global Cefepime Market Forecast
11.1 Global Cefepime Consumption Forecast (2021-2025)
11.2 Global Cefepime Forecast by Regions
11.2.1 Global Cefepime Forecast by Regions (2021-2025)
11.2.2 Global Cefepime Value Forecast by Regions (2021-2025)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Cefepime Forecast by Type
11.8 Global Cefepime Forecast by Application
12 Key Players Analysis
12.1 Baxter
12.1.1 Company Information
12.1.2 Cefepime Product Offered
12.1.3 Baxter Cefepime Sales, Revenue, Price and Gross Margin (2018-2020)
12.1.4 Main Business Overview
12.1.5 Baxter Latest Developments
12.2 BMS
12.2.1 Company Information
12.2.2 Cefepime Product Offered
12.2.3 BMS Cefepime Sales, Revenue, Price and Gross Margin (2018-2020)
12.2.4 Main Business Overview
12.2.5 BMS Latest Developments
12.3 Apotex
12.3.1 Company Information
12.3.2 Cefepime Product Offered
12.3.3 Apotex Cefepime Sales, Revenue, Price and Gross Margin (2018-2020)
12.3.4 Main Business Overview
12.3.5 Apotex Latest Developments
12.4 Pfizer
12.4.1 Company Information
12.4.2 Cefepime Product Offered
12.4.3 Pfizer Cefepime Sales, Revenue, Price and Gross Margin (2018-2020)
12.4.4 Main Business Overview
12.4.5 Pfizer Latest Developments
12.5 Perrigo
12.5.1 Company Information
12.5.2 Cefepime Product Offered
12.5.3 Perrigo Cefepime Sales, Revenue, Price and Gross Margin (2018-2020)
12.5.4 Main Business Overview
12.5.5 Perrigo Latest Developments
12.6 B. Braun Medical
12.6.1 Company Information
12.6.2 Cefepime Product Offered
12.6.3 B. Braun Medical Cefepime Sales, Revenue, Price and Gross Margin (2018-2020)
12.6.4 Main Business Overview
12.6.5 B. Braun Medical Latest Developments
12.7 Piramal Critical Care
12.7.1 Company Information
12.7.2 Cefepime Product Offered
12.7.3 Piramal Critical Care Cefepime Sales, Revenue, Price and Gross Margin (2018-2020)
12.7.4 Main Business Overview
12.7.5 Piramal Critical Care Latest Developments
12.8 Fresenius Kabi
12.8.1 Company Information
12.8.2 Cefepime Product Offered
12.8.3 Fresenius Kabi Cefepime Sales, Revenue, Price and Gross Margin (2018-2020)
12.8.4 Main Business Overview
12.8.5 Fresenius Kabi Latest Developments
12.9 Meitheal Pharmaceuticals
12.9.1 Company Information
12.9.2 Cefepime Product Offered
12.9.3 Meitheal Pharmaceuticals Cefepime Sales, Revenue, Price and Gross Margin (2018-2020)
12.9.4 Main Business Overview
12.9.5 Meitheal Pharmaceuticals Latest Developments
12.10 Sandoz (Novartis)
12.10.1 Company Information
12.10.2 Cefepime Product Offered
12.10.3 Sandoz (Novartis) Cefepime Sales, Revenue, Price and Gross Margin (2018-2020)
12.10.4 Main Business Overview
12.10.5 Sandoz (Novartis) Latest Developments
12.11 Shandong Luoxin Pharmaceutical Group
12.11.1 Company Information
12.11.2 Cefepime Product Offered
12.11.3 Shandong Luoxin Pharmaceutical Group Cefepime Sales, Revenue, Price and Gross Margin (2018-2020)
12.11.4 Main Business Overview
12.11.5 Shandong Luoxin Pharmaceutical Group Latest Developments
12.12 Yuekang Pharmaceutical Group
12.12.1 Company Information
12.12.2 Cefepime Product Offered
12.12.3 Yuekang Pharmaceutical Group Cefepime Sales, Revenue, Price and Gross Margin (2018-2020)
12.12.4 Main Business Overview
12.12.5 Yuekang Pharmaceutical Group Latest Developments
12.13 Guangzhou Baiyunshan Tianxin Pharmaceutical
12.13.1 Company Information
12.13.2 Cefepime Product Offered
12.13.3 Guangzhou Baiyunshan Tianxin Pharmaceutical Cefepime Sales, Revenue, Price and Gross Margin (2018-2020)
12.13.4 Main Business Overview
12.13.5 Guangzhou Baiyunshan Tianxin Pharmaceutical Latest Developments
12.14 Qilu Pharmaceutical
12.14.1 Company Information
12.14.2 Cefepime Product Offered
12.14.3 Qilu Pharmaceutical Cefepime Sales, Revenue, Price and Gross Margin (2018-2020)
12.14.4 Main Business Overview
12.14.5 Qilu Pharmaceutical Latest Developments
12.15 Hebei Huamin Pharmaceutical
12.15.1 Company Information
12.15.2 Cefepime Product Offered
12.15.3 Hebei Huamin Pharmaceutical Cefepime Sales, Revenue, Price and Gross Margin (2018-2020)
12.15.4 Main Business Overview
12.15.5 Hebei Huamin Pharmaceutical Latest Developments
12.16 Shanghai Xinfeng Pharmaceutical
12.16.1 Company Information
12.16.2 Cefepime Product Offered
12.16.3 Shanghai Xinfeng Pharmaceutical Cefepime Sales, Revenue, Price and Gross Margin (2018-2020)
12.16.4 Main Business Overview
12.16.5 Shanghai Xinfeng Pharmaceutical Latest Developments
12.17 Jiangsu Hengrui Pharmaceutical
12.17.1 Company Information
12.17.2 Cefepime Product Offered
12.17.3 Jiangsu Hengrui Pharmaceutical Cefepime Sales, Revenue, Price and Gross Margin (2018-2020)
12.17.4 Main Business Overview
12.17.5 Jiangsu Hengrui Pharmaceutical Latest Developments
12.18 Nanjing Haichen Pharmaceutical
12.18.1 Company Information
12.18.2 Cefepime Product Offered
12.18.3 Nanjing Haichen Pharmaceutical Cefepime Sales, Revenue, Price and Gross Margin (2018-2020)
12.18.4 Main Business Overview
12.18.5 Nanjing Haichen Pharmaceutical Latest Developments
12.19 Sinopharm
12.19.1 Company Information
12.19.2 Cefepime Product Offered
12.19.3 Sinopharm Cefepime Sales, Revenue, Price and Gross Margin (2018-2020)
12.19.4 Main Business Overview
12.19.5 Sinopharm Latest Developments
12.20 Chengdu Beite Pharmaceutical
12.20.1 Company Information
12.20.2 Cefepime Product Offered
12.20.3 Chengdu Beite Pharmaceutical Cefepime Sales, Revenue, Price and Gross Margin (2018-2020)
12.20.4 Main Business Overview
12.20.5 Chengdu Beite Pharmaceutical Latest Developments
12.21 Suzhou Dongrui Pharmaceutical
12.21.1 Company Information
12.21.2 Cefepime Product Offered
12.21.3 Suzhou Dongrui Pharmaceutical Cefepime Sales, Revenue, Price and Gross Margin (2018-2020)
12.21.4 Main Business Overview
12.21.5 Suzhou Dongrui Pharmaceutical Latest Developments
12.22 Hainan Hailing Pharmaceutical
12.22.1 Company Information
12.22.2 Cefepime Product Offered
12.22.3 Hainan Hailing Pharmaceutical Cefepime Sales, Revenue, Price and Gross Margin (2018-2020)
12.22.4 Main Business Overview
12.22.5 Hainan Hailing Pharmaceutical Latest Developments
12.23 Shenzhen Xinlitai Pharmaceutical
12.23.1 Company Information
12.23.2 Cefepime Product Offered
12.23.3 Shenzhen Xinlitai Pharmaceutical Cefepime Sales, Revenue, Price and Gross Margin (2018-2020)
12.23.4 Main Business Overview
12.23.5 Shenzhen Xinlitai Pharmaceutical Latest Developments
12.24 Hainan Star Pharmaceutical
12.24.1 Company Information
12.24.2 Cefepime Product Offered
12.24.3 Hainan Star Pharmaceutical Cefepime Sales, Revenue, Price and Gross Margin (2018-2020)
12.24.4 Main Business Overview
12.24.5 Hainan Star Pharmaceutical Latest Developments
12.25 Shenzhen Lijian Pharmaceutical
12.25.1 Company Information
12.25.2 Cefepime Product Offered
12.25.3 Shenzhen Lijian Pharmaceutical Cefepime Sales, Revenue, Price and Gross Margin (2018-2020)
12.25.4 Main Business Overview
12.25.5 Shenzhen Lijian Pharmaceutical Latest Developments
13 Research Findings and Conclusion
1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Cefepime Consumption 2015-2025
2.1.2 Cefepime Consumption CAGR by Region
2.2 Cefepime Segment by Type
2.2.1 Intramuscular Injection
2.2.2 Intravenous Drug Delivery
2.3 Cefepime Consumption by Type
2.3.1 Global Cefepime Consumption Market Share by Type (2015-2020)
2.3.2 Global Cefepime Revenue and Market Share by Type (2015-2020)
2.3.3 Global Cefepime Sale Price by Type (2015-2020)
2.4 Cefepime Segment by Application
2.4.1 Lower Respiratory Tract Infection
2.4.2 Urinary Tract Infection
2.4.3 Skin And Soft Tissue Infections
2.4.4 Abdominal Cavity Infection
2.4.5 Gynecologic Infection
2.4.6 Sepsis
2.4.7 Neutrophilic Fever
2.5 Cefepime Consumption by Application
2.5.1 Global Cefepime Consumption Market Share by Type (2015-2020)
2.5.2 Global Cefepime Value and Market Share by Type (2015-2020)
2.5.3 Global Cefepime Sale Price by Type (2015-2020)
3 Global Cefepime by Company
3.1 Global Cefepime Sales Market Share by Company
3.1.1 Global Cefepime Sales by Company (2018-2020)
3.1.2 Global Cefepime Sales Market Share by Company (2018-2020)
3.2 Global Cefepime Revenue Market Share by Company
3.2.1 Global Cefepime Revenue by Company (2018-2020)
3.2.2 Global Cefepime Revenue Market Share by Company (2018-2020)
3.3 Global Cefepime Sale Price by Company
3.4 Global Cefepime Manufacturing Base Distribution, Sales Area, Type by Company
3.4.1 Global Cefepime Manufacturing Base Distribution and Sales Area by Company
3.4.2 Players Cefepime Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 Cefepime by Regions
4.1 Cefepime by Regions
4.2 Americas Cefepime Consumption Growth
4.3 APAC Cefepime Consumption Growth
4.4 Europe Cefepime Consumption Growth
4.5 Middle East & Africa Cefepime Consumption Growth
5 Americas
5.1 Americas Cefepime Consumption by Countries
5.1.1 Americas Cefepime Consumption by Countries (2015-2020)
5.1.2 Americas Cefepime Value by Countries (2015-2020)
5.2 Americas Cefepime Consumption by Type
5.3 Americas Cefepime Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
5.8 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC Cefepime Consumption by Regions
6.1.1 APAC Cefepime Consumption by Regions (2015-2020)
6.1.2 APAC Cefepime Value by Regions (2015-2020)
6.2 APAC Cefepime Consumption by Type
6.3 APAC Cefepime Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions
7 Europe
7.1 Europe Cefepime by Countries
7.1.1 Europe Cefepime Consumption by Countries (2015-2020)
7.1.2 Europe Cefepime Value by Countries (2015-2020)
7.2 Europe Cefepime Consumption by Type
7.3 Europe Cefepime Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
8.1 Middle East & Africa Cefepime by Countries
8.1.1 Middle East & Africa Cefepime Consumption by Countries (2015-2020)
8.1.2 Middle East & Africa Cefepime Value by Countries (2015-2020)
8.2 Middle East & Africa Cefepime Consumption by Type
8.3 Middle East & Africa Cefepime Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Cefepime Distributors
10.3 Cefepime Customer
11 Global Cefepime Market Forecast
11.1 Global Cefepime Consumption Forecast (2021-2025)
11.2 Global Cefepime Forecast by Regions
11.2.1 Global Cefepime Forecast by Regions (2021-2025)
11.2.2 Global Cefepime Value Forecast by Regions (2021-2025)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Cefepime Forecast by Type
11.8 Global Cefepime Forecast by Application
12 Key Players Analysis
12.1 Baxter
12.1.1 Company Information
12.1.2 Cefepime Product Offered
12.1.3 Baxter Cefepime Sales, Revenue, Price and Gross Margin (2018-2020)
12.1.4 Main Business Overview
12.1.5 Baxter Latest Developments
12.2 BMS
12.2.1 Company Information
12.2.2 Cefepime Product Offered
12.2.3 BMS Cefepime Sales, Revenue, Price and Gross Margin (2018-2020)
12.2.4 Main Business Overview
12.2.5 BMS Latest Developments
12.3 Apotex
12.3.1 Company Information
12.3.2 Cefepime Product Offered
12.3.3 Apotex Cefepime Sales, Revenue, Price and Gross Margin (2018-2020)
12.3.4 Main Business Overview
12.3.5 Apotex Latest Developments
12.4 Pfizer
12.4.1 Company Information
12.4.2 Cefepime Product Offered
12.4.3 Pfizer Cefepime Sales, Revenue, Price and Gross Margin (2018-2020)
12.4.4 Main Business Overview
12.4.5 Pfizer Latest Developments
12.5 Perrigo
12.5.1 Company Information
12.5.2 Cefepime Product Offered
12.5.3 Perrigo Cefepime Sales, Revenue, Price and Gross Margin (2018-2020)
12.5.4 Main Business Overview
12.5.5 Perrigo Latest Developments
12.6 B. Braun Medical
12.6.1 Company Information
12.6.2 Cefepime Product Offered
12.6.3 B. Braun Medical Cefepime Sales, Revenue, Price and Gross Margin (2018-2020)
12.6.4 Main Business Overview
12.6.5 B. Braun Medical Latest Developments
12.7 Piramal Critical Care
12.7.1 Company Information
12.7.2 Cefepime Product Offered
12.7.3 Piramal Critical Care Cefepime Sales, Revenue, Price and Gross Margin (2018-2020)
12.7.4 Main Business Overview
12.7.5 Piramal Critical Care Latest Developments
12.8 Fresenius Kabi
12.8.1 Company Information
12.8.2 Cefepime Product Offered
12.8.3 Fresenius Kabi Cefepime Sales, Revenue, Price and Gross Margin (2018-2020)
12.8.4 Main Business Overview
12.8.5 Fresenius Kabi Latest Developments
12.9 Meitheal Pharmaceuticals
12.9.1 Company Information
12.9.2 Cefepime Product Offered
12.9.3 Meitheal Pharmaceuticals Cefepime Sales, Revenue, Price and Gross Margin (2018-2020)
12.9.4 Main Business Overview
12.9.5 Meitheal Pharmaceuticals Latest Developments
12.10 Sandoz (Novartis)
12.10.1 Company Information
12.10.2 Cefepime Product Offered
12.10.3 Sandoz (Novartis) Cefepime Sales, Revenue, Price and Gross Margin (2018-2020)
12.10.4 Main Business Overview
12.10.5 Sandoz (Novartis) Latest Developments
12.11 Shandong Luoxin Pharmaceutical Group
12.11.1 Company Information
12.11.2 Cefepime Product Offered
12.11.3 Shandong Luoxin Pharmaceutical Group Cefepime Sales, Revenue, Price and Gross Margin (2018-2020)
12.11.4 Main Business Overview
12.11.5 Shandong Luoxin Pharmaceutical Group Latest Developments
12.12 Yuekang Pharmaceutical Group
12.12.1 Company Information
12.12.2 Cefepime Product Offered
12.12.3 Yuekang Pharmaceutical Group Cefepime Sales, Revenue, Price and Gross Margin (2018-2020)
12.12.4 Main Business Overview
12.12.5 Yuekang Pharmaceutical Group Latest Developments
12.13 Guangzhou Baiyunshan Tianxin Pharmaceutical
12.13.1 Company Information
12.13.2 Cefepime Product Offered
12.13.3 Guangzhou Baiyunshan Tianxin Pharmaceutical Cefepime Sales, Revenue, Price and Gross Margin (2018-2020)
12.13.4 Main Business Overview
12.13.5 Guangzhou Baiyunshan Tianxin Pharmaceutical Latest Developments
12.14 Qilu Pharmaceutical
12.14.1 Company Information
12.14.2 Cefepime Product Offered
12.14.3 Qilu Pharmaceutical Cefepime Sales, Revenue, Price and Gross Margin (2018-2020)
12.14.4 Main Business Overview
12.14.5 Qilu Pharmaceutical Latest Developments
12.15 Hebei Huamin Pharmaceutical
12.15.1 Company Information
12.15.2 Cefepime Product Offered
12.15.3 Hebei Huamin Pharmaceutical Cefepime Sales, Revenue, Price and Gross Margin (2018-2020)
12.15.4 Main Business Overview
12.15.5 Hebei Huamin Pharmaceutical Latest Developments
12.16 Shanghai Xinfeng Pharmaceutical
12.16.1 Company Information
12.16.2 Cefepime Product Offered
12.16.3 Shanghai Xinfeng Pharmaceutical Cefepime Sales, Revenue, Price and Gross Margin (2018-2020)
12.16.4 Main Business Overview
12.16.5 Shanghai Xinfeng Pharmaceutical Latest Developments
12.17 Jiangsu Hengrui Pharmaceutical
12.17.1 Company Information
12.17.2 Cefepime Product Offered
12.17.3 Jiangsu Hengrui Pharmaceutical Cefepime Sales, Revenue, Price and Gross Margin (2018-2020)
12.17.4 Main Business Overview
12.17.5 Jiangsu Hengrui Pharmaceutical Latest Developments
12.18 Nanjing Haichen Pharmaceutical
12.18.1 Company Information
12.18.2 Cefepime Product Offered
12.18.3 Nanjing Haichen Pharmaceutical Cefepime Sales, Revenue, Price and Gross Margin (2018-2020)
12.18.4 Main Business Overview
12.18.5 Nanjing Haichen Pharmaceutical Latest Developments
12.19 Sinopharm
12.19.1 Company Information
12.19.2 Cefepime Product Offered
12.19.3 Sinopharm Cefepime Sales, Revenue, Price and Gross Margin (2018-2020)
12.19.4 Main Business Overview
12.19.5 Sinopharm Latest Developments
12.20 Chengdu Beite Pharmaceutical
12.20.1 Company Information
12.20.2 Cefepime Product Offered
12.20.3 Chengdu Beite Pharmaceutical Cefepime Sales, Revenue, Price and Gross Margin (2018-2020)
12.20.4 Main Business Overview
12.20.5 Chengdu Beite Pharmaceutical Latest Developments
12.21 Suzhou Dongrui Pharmaceutical
12.21.1 Company Information
12.21.2 Cefepime Product Offered
12.21.3 Suzhou Dongrui Pharmaceutical Cefepime Sales, Revenue, Price and Gross Margin (2018-2020)
12.21.4 Main Business Overview
12.21.5 Suzhou Dongrui Pharmaceutical Latest Developments
12.22 Hainan Hailing Pharmaceutical
12.22.1 Company Information
12.22.2 Cefepime Product Offered
12.22.3 Hainan Hailing Pharmaceutical Cefepime Sales, Revenue, Price and Gross Margin (2018-2020)
12.22.4 Main Business Overview
12.22.5 Hainan Hailing Pharmaceutical Latest Developments
12.23 Shenzhen Xinlitai Pharmaceutical
12.23.1 Company Information
12.23.2 Cefepime Product Offered
12.23.3 Shenzhen Xinlitai Pharmaceutical Cefepime Sales, Revenue, Price and Gross Margin (2018-2020)
12.23.4 Main Business Overview
12.23.5 Shenzhen Xinlitai Pharmaceutical Latest Developments
12.24 Hainan Star Pharmaceutical
12.24.1 Company Information
12.24.2 Cefepime Product Offered
12.24.3 Hainan Star Pharmaceutical Cefepime Sales, Revenue, Price and Gross Margin (2018-2020)
12.24.4 Main Business Overview
12.24.5 Hainan Star Pharmaceutical Latest Developments
12.25 Shenzhen Lijian Pharmaceutical
12.25.1 Company Information
12.25.2 Cefepime Product Offered
12.25.3 Shenzhen Lijian Pharmaceutical Cefepime Sales, Revenue, Price and Gross Margin (2018-2020)
12.25.4 Main Business Overview
12.25.5 Shenzhen Lijian Pharmaceutical Latest Developments
13 Research Findings and Conclusion
List of Tables
Table 1. Research Methodology
Table 2. Data Source
Table 3. Cefepime Consumption CAGR by Region 2015-2025 ($ Millions)
Table 4. Major Players of Intramuscular Injection
Table 5. Major Players of Intravenous Drug Delivery
Table 6. Global Consumption Sales by Type (2015-2020)
Table 7. Global Cefepime Consumption Market Share by Type (2015-2020)
Table 8. Global Cefepime Revenue by Type (2015-2020) ($ million)
Table 9. Global Cefepime Value Market Share by Type (2015-2020) ($ Millions)
Table 10. Global Cefepime Sale Price by Type (2015-2020)
Table 11. Global Consumption Sales by Application (2015-2020)
Table 12. Global Cefepime Consumption Market Share by Application (2015-2020)
Table 13. Global Cefepime Value by Application (2015-2020)
Table 14. Global Cefepime Value Market Share by Application (2015-2020)
Table 15. Global Cefepime Sale Price by Application (2015-2020)
Table 16. Global Cefepime Sales by Company (2017-2019) (K Units)
Table 17. Global Cefepime Sales Market Share by Company (2017-2019)
Table 18. Global Cefepime Revenue by Company (2017-2019) ($ Millions)
Table 19. Global Cefepime Revenue Market Share by Company (2017-2019)
Table 20. Global Cefepime Sale Price by Company (2017-2019)
Table 21. Global Cefepime Manufacturing Base Distribution and Sales Area by Manufacturers
Table 22. Players Cefepime Products Offered
Table 23. Cefepime Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
Table 24. Global Cefepime Consumption by Regions 2015-2020 (K Units)
Table 25. Global Cefepime Consumption Market Share by Regions 2015-2020
Table 26. Global Cefepime Value by Regions 2015-2020 ($ Millions)
Table 27. Global Cefepime Value Market Share by Regions 2015-2020
Table 28. Americas Cefepime Consumption by Countries (2015-2020) (K Units)
Table 29. Americas Cefepime Consumption Market Share by Countries (2015-2020)
Table 30. Americas Cefepime Value by Countries (2015-2020) ($ Millions)
Table 31. Americas Cefepime Value Market Share by Countries (2015-2020)
Table 32. Americas Cefepime Consumption by Type (2015-2020) (K Units)
Table 33. Americas Cefepime Consumption Market Share by Type (2015-2020)
Table 34. Americas Cefepime Consumption by Application (2015-2020) (K Units)
Table 35. Americas Cefepime Consumption Market Share by Application (2015-2020)
Table 36. APAC Cefepime Consumption by Countries (2015-2020) (K Units)
Table 37. APAC Cefepime Consumption Market Share by Countries (2015-2020)
Table 38. APAC Cefepime Value by Regions (2015-2020) ($ Millions)
Table 39. APAC Cefepime Value Market Share by Regions (2015-2020)
Table 40. APAC Cefepime Consumption by Type (2015-2020) (K Units)
Table 41. APAC Cefepime Consumption Market Share by Type (2015-2020)
Table 42. APAC Cefepime Consumption by Application (2015-2020) (K Units)
Table 43. APAC Cefepime Consumption Market Share by Application (2015-2020)
Table 44. Europe Cefepime Consumption by Countries (2015-2020) (K Units)
Table 45. Europe Cefepime Consumption Market Share by Countries (2015-2020)
Table 46. Europe Cefepime Value by Countries (2015-2020) ($ Millions)
Table 47. Europe Cefepime Value Market Share by Countries (2015-2020)
Table 48. Europe Cefepime Consumption by Type (2015-2020) (K Units)
Table 49. Europe Cefepime Consumption Market Share by Type (2015-2020)
Table 50. Europe Cefepime Consumption by Application (2015-2020) (K Units)
Table 51. Europe Cefepime Consumption Market Share by Application (2015-2020)
Table 52. Middle East & Africa Cefepime Consumption by Countries (2015-2020) (K Units)
Table 53. Middle East & Africa Cefepime Consumption Market Share by Countries (2015-2020)
Table 54. Middle East & Africa Cefepime Value by Countries (2015-2020) ($ Millions)
Table 55. Middle East & Africa Cefepime Value Market Share by Countries (2015-2020)
Table 56. Middle East & Africa Cefepime Consumption by Type (2015-2020) (K Units)
Table 57. Middle East & Africa Cefepime Consumption Market Share by Type (2015-2020)
Table 58. Middle East & Africa Cefepime Consumption by Application (2015-2020) (K Units)
Table 59. Middle East & Africa Cefepime Consumption Market Share by Application (2015-2020)
Table 60. Cefepime Distributors List
Table 61. Cefepime Customer List
Table 62. Global Cefepime Consumption Forecast by Countries (2021-2025) (K Units)
Table 63. Global Cefepime Consumption Market Forecast by Regions
Table 64. Global Cefepime Value Forecast by Countries (2021-2025) ($ Millions)
Table 65. Global Cefepime Value Market Share Forecast by Regions
Table 66. Global Cefepime Consumption Forecast by Type (2021-2025) (K Units)
Table 67. Global Cefepime Consumption Market Share Forecast by Type (2021-2025)
Table 68. Global Cefepime Value Forecast by Type (2021-2025) ($ Millions)
Table 69. Global Cefepime Value Market Share Forecast by Type (2021-2025)
Table 70. Global Cefepime Consumption Forecast by Application (2021-2025) (K Units)
Table 71. Global Cefepime Consumption Market Share Forecast by Application (2021-2025)
Table 72. Global Cefepime Value Forecast by Application (2021-2025) ($ Millions)
Table 73. Global Cefepime Value Market Share Forecast by Application (2021-2025)
Table 74. Baxter Product Offered
Table 75. Baxter Cefepime Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 76. Baxter Main Business
Table 77. Baxter Latest Developments
Table 78. Baxter Basic Information, Company Total Revenue (in $ million), Cefepime Manufacturing Base, Sales Area and Its Competitors
Table 79. BMS Product Offered
Table 80. BMS Cefepime Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 81. BMS Main Business
Table 82. BMS Latest Developments
Table 83. BMS Basic Information, Company Total Revenue (in $ million), Cefepime Manufacturing Base, Sales Area and Its Competitors
Table 84. Apotex Product Offered
Table 85. Apotex Cefepime Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 86. Apotex Main Business
Table 87. Apotex Latest Developments
Table 88. Apotex Basic Information, Company Total Revenue (in $ million), Cefepime Manufacturing Base, Sales Area and Its Competitors
Table 89. Pfizer Product Offered
Table 90. Pfizer Cefepime Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 91. Pfizer Main Business
Table 92. Pfizer Latest Developments
Table 93. Pfizer Basic Information, Company Total Revenue (in $ million), Cefepime Manufacturing Base, Sales Area and Its Competitors
Table 94. Perrigo Product Offered
Table 95. Perrigo Cefepime Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 96. Perrigo Main Business
Table 97. Perrigo Latest Developments
Table 98. Perrigo Basic Information, Company Total Revenue (in $ million), Cefepime Manufacturing Base, Sales Area and Its Competitors
Table 99. B. Braun Medical Product Offered
Table 100. B. Braun Medical Cefepime Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 101. B. Braun Medical Main Business
Table 102. B. Braun Medical Latest Developments
Table 103. B. Braun Medical Basic Information, Company Total Revenue (in $ million), Cefepime Manufacturing Base, Sales Area and Its Competitors
Table 104. Piramal Critical Care Product Offered
Table 105. Piramal Critical Care Basic Information, Company Total Revenue (in $ million), Cefepime Manufacturing Base, Sales Area and Its Competitors
Table 106. Piramal Critical Care Main Business
Table 107. Piramal Critical Care Latest Developments
Table 108. Piramal Critical Care Cefepime Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 109. Fresenius Kabi Product Offered
Table 110. Fresenius Kabi Cefepime Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 111. Fresenius Kabi Main Business
Table 112. Fresenius Kabi Latest Developments
Table 113. Fresenius Kabi Basic Information, Company Total Revenue (in $ million), Cefepime Manufacturing Base, Sales Area and Its Competitors
Table 114. Meitheal Pharmaceuticals Product Offered
Table 115. Meitheal Pharmaceuticals Cefepime Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 116. Meitheal Pharmaceuticals Main Business
Table 117. Meitheal Pharmaceuticals Latest Developments
Table 118. Meitheal Pharmaceuticals Basic Information, Company Total Revenue (in $ million), Cefepime Manufacturing Base, Sales Area and Its Competitors
Table 119. Sandoz (Novartis) Product Offered
Table 120. Sandoz (Novartis) Cefepime Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 121. Sandoz (Novartis) Main Business
Table 122. Sandoz (Novartis) Latest Developments
Table 123. Sandoz (Novartis) Basic Information, Company Total Revenue (in $ million), Cefepime Manufacturing Base, Sales Area and Its Competitors
Table 124. Shandong Luoxin Pharmaceutical Group Product Offered
Table 125. Shandong Luoxin Pharmaceutical Group Cefepime Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 126. Shandong Luoxin Pharmaceutical Group Main Business
Table 127. Shandong Luoxin Pharmaceutical Group Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 128. Shandong Luoxin Pharmaceutical Group Latest Developments
Table 129. Yuekang Pharmaceutical Group Product Offered
Table 130. Yuekang Pharmaceutical Group Cefepime Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 131. Yuekang Pharmaceutical Group Main Business
Table 132. Yuekang Pharmaceutical Group Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 133. Yuekang Pharmaceutical Group Latest Developments
Table 134. Guangzhou Baiyunshan Tianxin Pharmaceutical Product Offered
Table 135. Guangzhou Baiyunshan Tianxin Pharmaceutical Cefepime Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 136. Guangzhou Baiyunshan Tianxin Pharmaceutical Main Business
Table 137. Guangzhou Baiyunshan Tianxin Pharmaceutical Latest Developments
Table 138. Guangzhou Baiyunshan Tianxin Pharmaceutical Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 139. Qilu Pharmaceutical Product Offered
Table 140. Qilu Pharmaceutical Cefepime Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 141. Qilu Pharmaceutical Main Business
Table 142. Qilu Pharmaceutical Latest Developments
Table 143. Qilu Pharmaceutical Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 144. Hebei Huamin Pharmaceutical Product Offered
Table 145. Hebei Huamin Pharmaceutical Cefepime Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 146. Hebei Huamin Pharmaceutical Main Business
Table 147. Hebei Huamin Pharmaceutical Latest Developments
Table 148. Hebei Huamin Pharmaceutical Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 149. Shanghai Xinfeng Pharmaceutical Product Offered
Table 150. Shanghai Xinfeng Pharmaceutical Cefepime Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 151. Shanghai Xinfeng Pharmaceutical Main Business
Table 152. Shanghai Xinfeng Pharmaceutical Latest Developments
Table 153. Shanghai Xinfeng Pharmaceutical Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 154. Jiangsu Hengrui Pharmaceutical Product Offered
Table 155. Jiangsu Hengrui Pharmaceutical Cefepime Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 156. Jiangsu Hengrui Pharmaceutical Main Business
Table 157. Jiangsu Hengrui Pharmaceutical Latest Developments
Table 158. Jiangsu Hengrui Pharmaceutical Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 159. Nanjing Haichen Pharmaceutical Product Offered
Table 160. Nanjing Haichen Pharmaceutical Cefepime Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 161. Nanjing Haichen Pharmaceutical Main Business
Table 162. Nanjing Haichen Pharmaceutical Latest Developments
Table 163. Nanjing Haichen Pharmaceutical Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 164. Sinopharm Product Offered
Table 165. Sinopharm Cefepime Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 166. Sinopharm Main Business
Table 167. Sinopharm Latest Developments
Table 168. Sinopharm Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 169. Chengdu Beite Pharmaceutical Product Offered
Table 170. Chengdu Beite Pharmaceutical Cefepime Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 171. Chengdu Beite Pharmaceutical Main Business
Table 172. Chengdu Beite Pharmaceutical Latest Developments
Table 173. Chengdu Beite Pharmaceutical Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 174. Suzhou Dongrui Pharmaceutical Product Offered
Table 175. Suzhou Dongrui Pharmaceutical Cefepime Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 176. Suzhou Dongrui Pharmaceutical Main Business
Table 177. Suzhou Dongrui Pharmaceutical Latest Developments
Table 178. Suzhou Dongrui Pharmaceutical Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 179. Hainan Hailing Pharmaceutical Product Offered
Table 180. Hainan Hailing Pharmaceutical Cefepime Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 181. Hainan Hailing Pharmaceutical Main Business
Table 182. Hainan Hailing Pharmaceutical Latest Developments
Table 183. Hainan Hailing Pharmaceutical Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 184. Shenzhen Xinlitai Pharmaceutical Product Offered
Table 185. Shenzhen Xinlitai Pharmaceutical Cefepime Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 186. Shenzhen Xinlitai Pharmaceutical Main Business
Table 187. Shenzhen Xinlitai Pharmaceutical Latest Developments
Table 188. Shenzhen Xinlitai Pharmaceutical Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 189. Hainan Star Pharmaceutical Product Offered
Table 190. Hainan Star Pharmaceutical Cefepime Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 191. Hainan Star Pharmaceutical Main Business
Table 192. Hainan Star Pharmaceutical Latest Developments
Table 193. Hainan Star Pharmaceutical Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 194. Shenzhen Lijian Pharmaceutical Product Offered
Table 195. Shenzhen Lijian Pharmaceutical Cefepime Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 196. Shenzhen Lijian Pharmaceutical Main Business
Table 197. Shenzhen Lijian Pharmaceutical Latest Developments
Table 198. Shenzhen Lijian Pharmaceutical Basic Information, Manufacturing Base, Sales Area and Its Competitors
List of Figures
Figure 1. Picture of Cefepime
Figure 2. Cefepime Report Years Considered
Figure 3. Market Research Methodology
Figure 4. Global Cefepime Consumption Growth Rate 2015-2025 (K Units)
Figure 5. Global Cefepime Value Growth Rate 2015-2025 ($ Millions)
Figure 6. Product Picture of Intramuscular Injection
Figure 7. Product Picture of Intravenous Drug Delivery
Figure 8. Global Cefepime Consumption Market Share by Type (2015-2020)
Figure 9. Global Cefepime Value Market Share by Type (2015-2020)
Figure 10. Cefepime Consumed in Lower Respiratory Tract Infection
Figure 11. Global Cefepime Market: Lower Respiratory Tract Infection (2015-2020) (K Units)
Figure 12. Global Cefepime Market: Lower Respiratory Tract Infection (2015-2020) ($ Millions)
Figure 13. Cefepime Consumed in Urinary Tract Infection
Figure 14. Global Cefepime Market: Urinary Tract Infection (2015-2020) (K Units)
Figure 15. Global Cefepime Market: Urinary Tract Infection (2015-2020) ($ Millions)
Figure 16. Cefepime Consumed in Skin And Soft Tissue Infections
Figure 17. Global Cefepime Market: Skin And Soft Tissue Infections (2015-2020) (K Units)
Figure 18. Global Cefepime Market: Skin And Soft Tissue Infections (2015-2020) ($ Millions)
Figure 19. Cefepime Consumed in Abdominal Cavity Infection
Figure 20. Global Cefepime Market: Abdominal Cavity Infection (2015-2020) (K Units)
Figure 21. Global Cefepime Market: Abdominal Cavity Infection (2015-2020) ($ Millions)
Figure 22. Cefepime Consumed in Gynecologic Infection
Figure 23. Global Cefepime Market: Gynecologic Infection (2015-2020) (K Units)
Figure 24. Global Cefepime Market: Gynecologic Infection (2015-2020) ($ Millions)
Figure 25. Cefepime Consumed in Sepsis
Figure 26. Cefepime Consumed in Neutrophilic Fever
Figure 27. Global Cefepime Consumption Market Share by Application (2015-2020)
Figure 28. Global Cefepime Value Market Share by Application (2015-2020)
Figure 29. Global Cefepime Sales Market Share by Company in 2017
Figure 30. Global Cefepime Sales Market Share by Company in 2019
Figure 31. Global Cefepime Revenue Market Share by Company in 2017
Figure 32. Global Cefepime Revenue Market Share by Company in 2019
Figure 33. Global Cefepime Sale Price by Company in 2019
Figure 34. Global Cefepime Consumption Market Share by Regions 2015-2020
Figure 35. Global Cefepime Value Market Share by Regions 2015-2020
Figure 36. Americas Cefepime Consumption 2015-2020 (K Units)
Figure 37. Americas Cefepime Value 2015-2020 ($ Millions)
Figure 38. APAC Cefepime Consumption 2015-2020 (K Units)
Figure 39. APAC Cefepime Value 2015-2020 ($ Millions)
Figure 40. Europe Cefepime Consumption 2015-2020 (K Units)
Figure 41. Europe Cefepime Value 2015-2020 ($ Millions)
Figure 42. Middle East & Africa Cefepime Consumption 2015-2020 (K Units)
Figure 43. Middle East & Africa Cefepime Value 2015-2020 ($ Millions)
Figure 44. Americas Cefepime Consumption Market Share by Countries in 2019
Figure 45. Americas Cefepime Value Market Share by Countries in 2019
Figure 46. Americas Cefepime Consumption Market Share by Type in 2019
Figure 47. Americas Cefepime Consumption Market Share by Application in 2019
Figure 48. United States Cefepime Consumption Growth 2015-2020 (K Units)
Figure 49. United States Cefepime Value Growth 2015-2020 ($ Millions)
Figure 50. Canada Cefepime Consumption Growth 2015-2020 (K Units)
Figure 51. Canada Cefepime Value Growth 2015-2020 ($ Millions)
Figure 52. Mexico Cefepime Consumption Growth 2015-2020 (K Units)
Figure 53. Mexico Cefepime Value Growth 2015-2020 ($ Millions)
Figure 54. APAC Cefepime Consumption Market Share by Countries in 2019
Figure 55. APAC Cefepime Value Market Share by Regions in 2019
Figure 56. APAC Cefepime Consumption Market Share by Type in 2019
Figure 57. APAC Cefepime Consumption Market Share by Application in 2019
Figure 58. China Cefepime Consumption Growth 2015-2020 (K Units)
Figure 59. China Cefepime Value Growth 2015-2020 ($ Millions)
Figure 60. Japan Cefepime Consumption Growth 2015-2020 (K Units)
Figure 61. Japan Cefepime Value Growth 2015-2020 ($ Millions)
Figure 62. Korea Cefepime Consumption Growth 2015-2020 (K Units)
Figure 63. Korea Cefepime Value Growth 2015-2020 ($ Millions)
Figure 64. Southeast Asia Cefepime Consumption Growth 2015-2020 (K Units)
Figure 65. Southeast Asia Cefepime Value Growth 2015-2020 ($ Millions)
Figure 66. India Cefepime Consumption Growth 2015-2020 (K Units)
Figure 67. India Cefepime Value Growth 2015-2020 ($ Millions)
Figure 68. Australia Cefepime Consumption Growth 2015-2020 (K Units)
Figure 69. Australia Cefepime Value Growth 2015-2020 ($ Millions)
Figure 70. Europe Cefepime Consumption Market Share by Countries in 2019
Figure 71. Europe Cefepime Value Market Share by Countries in 2019
Figure 72. Europe Cefepime Consumption Market Share by Type in 2019
Figure 73. Europe Cefepime Consumption Market Share by Application in 2019
Figure 74. Germany Cefepime Consumption Growth 2015-2020 (K Units)
Figure 75. Germany Cefepime Value Growth 2015-2020 ($ Millions)
Figure 76. France Cefepime Consumption Growth 2015-2020 (K Units)
Figure 77. France Cefepime Value Growth 2015-2020 ($ Millions)
Figure 78. UK Cefepime Consumption Growth 2015-2020 (K Units)
Figure 79. UK Cefepime Value Growth 2015-2020 ($ Millions)
Figure 80. Italy Cefepime Consumption Growth 2015-2020 (K Units)
Figure 81. Italy Cefepime Value Growth 2015-2020 ($ Millions)
Figure 82. Russia Cefepime Consumption Growth 2015-2020 (K Units)
Figure 83. Russia Cefepime Value Growth 2015-2020 ($ Millions)
Figure 84. Middle East & Africa Cefepime Consumption Market Share by Countries in 2019
Figure 85. Middle East & Africa Cefepime Value Market Share by Countries in 2019
Figure 86. Middle East & Africa Cefepime Consumption Market Share by Type in 2019
Figure 87. Middle East & Africa Cefepime Consumption Market Share by Application in 2019
Figure 88. Egypt Cefepime Consumption Growth 2015-2020 (K Units)
Figure 89. Egypt Cefepime Value Growth 2015-2020 ($ Millions)
Figure 90. South Africa Cefepime Consumption Growth 2015-2020 (K Units)
Figure 91. South Africa Cefepime Value Growth 2015-2020 ($ Millions)
Figure 92. Israel Cefepime Consumption Growth 2015-2020 (K Units)
Figure 93. Israel Cefepime Value Growth 2015-2020 ($ Millions)
Figure 94. Turkey Cefepime Consumption Growth 2015-2020 (K Units)
Figure 95. Turkey Cefepime Value Growth 2015-2020 ($ Millions)
Figure 96. GCC Countries Cefepime Consumption Growth 2015-2020 (K Units)
Figure 97. GCC Countries Cefepime Value Growth 2015-2020 ($ Millions)
Figure 98. Global Cefepime Consumption Growth Rate Forecast (2021-2025) (K Units)
Figure 99. Global Cefepime Value Growth Rate Forecast (2021-2025) ($ Millions)
Figure 100. Americas Cefepime Consumption 2021-2025 (K Units)
Figure 101. Americas Cefepime Value 2021-2025 ($ Millions)
Figure 102. APAC Cefepime Consumption 2021-2025 (K Units)
Figure 103. APAC Cefepime Value 2021-2025 ($ Millions)
Figure 104. Europe Cefepime Consumption 2021-2025 (K Units)
Figure 105. Europe Cefepime Value 2021-2025 ($ Millions)
Figure 106. Middle East & Africa Cefepime Consumption 2021-2025 (K Units)
Figure 107. Middle East & Africa Cefepime Value 2021-2025 ($ Millions)
Figure 108. United States Cefepime Consumption 2021-2025 (K Units)
Figure 109. United States Cefepime Value 2021-2025 ($ Millions)
Figure 110. Canada Cefepime Consumption 2021-2025 (K Units)
Figure 111. Canada Cefepime Value 2021-2025 ($ Millions)
Figure 112. Mexico Cefepime Consumption 2021-2025 (K Units)
Figure 113. Mexico Cefepime Value 2021-2025 ($ Millions)
Figure 114. Brazil Cefepime Consumption 2021-2025 (K Units)
Figure 115. Brazil Cefepime Value 2021-2025 ($ Millions)
Figure 116. China Cefepime Consumption 2021-2025 (K Units)
Figure 117. China Cefepime Value 2021-2025 ($ Millions)
Figure 118. Japan Cefepime Consumption 2021-2025 (K Units)
Figure 119. Japan Cefepime Value 2021-2025 ($ Millions)
Figure 120. Korea Cefepime Consumption 2021-2025 (K Units)
Figure 121. Korea Cefepime Value 2021-2025 ($ Millions)
Figure 122. Southeast Asia Cefepime Consumption 2021-2025 (K Units)
Figure 123. Southeast Asia Cefepime Value 2021-2025 ($ Millions)
Figure 124. India Cefepime Consumption 2021-2025 (K Units)
Figure 125. India Cefepime Value 2021-2025 ($ Millions)
Figure 126. Australia Cefepime Consumption 2021-2025 (K Units)
Figure 127. Australia Cefepime Value 2021-2025 ($ Millions)
Figure 128. Germany Cefepime Consumption 2021-2025 (K Units)
Figure 129. Germany Cefepime Value 2021-2025 ($ Millions)
Figure 130. France Cefepime Consumption 2021-2025 (K Units)
Figure 131. France Cefepime Value 2021-2025 ($ Millions)
Figure 132. UK Cefepime Consumption 2021-2025 (K Units)
Figure 133. UK Cefepime Value 2021-2025 ($ Millions)
Figure 134. Italy Cefepime Consumption 2021-2025 (K Units)
Figure 135. Italy Cefepime Value 2021-2025 ($ Millions)
Figure 136. Russia Cefepime Consumption 2021-2025 (K Units)
Figure 137. Russia Cefepime Value 2021-2025 ($ Millions)
Figure 138. Spain Cefepime Consumption 2021-2025 (K Units)
Figure 139. Spain Cefepime Value 2021-2025 ($ Millions)
Figure 140. Egypt Cefepime Consumption 2021-2025 (K Units)
Figure 141. Egypt Cefepime Value 2021-2025 ($ Millions)
Figure 142. South Africa Cefepime Consumption 2021-2025 (K Units)
Figure 143. South Africa Cefepime Value 2021-2025 ($ Millions)
Figure 144. Israel Cefepime Consumption 2021-2025 (K Units)
Figure 145. Israel Cefepime Value 2021-2025 ($ Millions)
Figure 146. Turkey Cefepime Consumption 2021-2025 (K Units)
Figure 147. Turkey Cefepime Value 2021-2025 ($ Millions)
Figure 148. GCC Countries Cefepime Consumption 2021-2025 (K Units)
Figure 149. GCC Countries Cefepime Value 2021-2025 ($ Millions)
Figure 150. Baxter Cefepime Market Share (2018-2020)
Figure 151. BMS Cefepime Market Share (2018-2020)
Figure 152. Apotex Cefepime Market Share (2018-2020)
Figure 153. Pfizer Cefepime Market Share (2018-2020)
Figure 154. Perrigo Cefepime Market Share (2018-2020)
Figure 155. B. Braun Medical Cefepime Market Share (2018-2020)
Figure 156. Piramal Critical Care Cefepime Market Share (2018-2020)
Figure 157. Fresenius Kabi Cefepime Market Share (2018-2020)
Figure 158. Meitheal Pharmaceuticals Cefepime Market Share (2018-2020)
Figure 159. Sandoz (Novartis) Cefepime Market Share (2018-2020)
Figure 160. Shandong Luoxin Pharmaceutical Group Cefepime Market Share (2018-2020)
Figure 161. Yuekang Pharmaceutical Group Cefepime Market Share (2018-2020)
Figure 162. Guangzhou Baiyunshan Tianxin Pharmaceutical Cefepime Market Share (2018-2020)
Figure 163. Qilu Pharmaceutical Cefepime Market Share (2018-2020)
Figure 164. Hebei Huamin Pharmaceutical Cefepime Market Share (2018-2020)
Figure 165. Shanghai Xinfeng Pharmaceutical Cefepime Market Share (2018-2020)
Figure 166. Jiangsu Hengrui Pharmaceutical Cefepime Market Share (2018-2020)
Figure 167. Nanjing Haichen Pharmaceutical Cefepime Market Share (2018-2020)
Figure 168. Sinopharm Cefepime Market Share (2018-2020)
Figure 169. Chengdu Beite Pharmaceutical Cefepime Market Share (2018-2020)
Figure 170. Suzhou Dongrui Pharmaceutical Cefepime Market Share (2018-2020)
Figure 171. Hainan Hailing Pharmaceutical Cefepime Market Share (2018-2020)
Figure 172. Shenzhen Xinlitai Pharmaceutical Cefepime Market Share (2018-2020)
Figure 173. Hainan Star Pharmaceutical Cefepime Market Share (2018-2020)
Figure 174. Shenzhen Lijian Pharmaceutical Cefepime Market Share (2018-2020)
Table 1. Research Methodology
Table 2. Data Source
Table 3. Cefepime Consumption CAGR by Region 2015-2025 ($ Millions)
Table 4. Major Players of Intramuscular Injection
Table 5. Major Players of Intravenous Drug Delivery
Table 6. Global Consumption Sales by Type (2015-2020)
Table 7. Global Cefepime Consumption Market Share by Type (2015-2020)
Table 8. Global Cefepime Revenue by Type (2015-2020) ($ million)
Table 9. Global Cefepime Value Market Share by Type (2015-2020) ($ Millions)
Table 10. Global Cefepime Sale Price by Type (2015-2020)
Table 11. Global Consumption Sales by Application (2015-2020)
Table 12. Global Cefepime Consumption Market Share by Application (2015-2020)
Table 13. Global Cefepime Value by Application (2015-2020)
Table 14. Global Cefepime Value Market Share by Application (2015-2020)
Table 15. Global Cefepime Sale Price by Application (2015-2020)
Table 16. Global Cefepime Sales by Company (2017-2019) (K Units)
Table 17. Global Cefepime Sales Market Share by Company (2017-2019)
Table 18. Global Cefepime Revenue by Company (2017-2019) ($ Millions)
Table 19. Global Cefepime Revenue Market Share by Company (2017-2019)
Table 20. Global Cefepime Sale Price by Company (2017-2019)
Table 21. Global Cefepime Manufacturing Base Distribution and Sales Area by Manufacturers
Table 22. Players Cefepime Products Offered
Table 23. Cefepime Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
Table 24. Global Cefepime Consumption by Regions 2015-2020 (K Units)
Table 25. Global Cefepime Consumption Market Share by Regions 2015-2020
Table 26. Global Cefepime Value by Regions 2015-2020 ($ Millions)
Table 27. Global Cefepime Value Market Share by Regions 2015-2020
Table 28. Americas Cefepime Consumption by Countries (2015-2020) (K Units)
Table 29. Americas Cefepime Consumption Market Share by Countries (2015-2020)
Table 30. Americas Cefepime Value by Countries (2015-2020) ($ Millions)
Table 31. Americas Cefepime Value Market Share by Countries (2015-2020)
Table 32. Americas Cefepime Consumption by Type (2015-2020) (K Units)
Table 33. Americas Cefepime Consumption Market Share by Type (2015-2020)
Table 34. Americas Cefepime Consumption by Application (2015-2020) (K Units)
Table 35. Americas Cefepime Consumption Market Share by Application (2015-2020)
Table 36. APAC Cefepime Consumption by Countries (2015-2020) (K Units)
Table 37. APAC Cefepime Consumption Market Share by Countries (2015-2020)
Table 38. APAC Cefepime Value by Regions (2015-2020) ($ Millions)
Table 39. APAC Cefepime Value Market Share by Regions (2015-2020)
Table 40. APAC Cefepime Consumption by Type (2015-2020) (K Units)
Table 41. APAC Cefepime Consumption Market Share by Type (2015-2020)
Table 42. APAC Cefepime Consumption by Application (2015-2020) (K Units)
Table 43. APAC Cefepime Consumption Market Share by Application (2015-2020)
Table 44. Europe Cefepime Consumption by Countries (2015-2020) (K Units)
Table 45. Europe Cefepime Consumption Market Share by Countries (2015-2020)
Table 46. Europe Cefepime Value by Countries (2015-2020) ($ Millions)
Table 47. Europe Cefepime Value Market Share by Countries (2015-2020)
Table 48. Europe Cefepime Consumption by Type (2015-2020) (K Units)
Table 49. Europe Cefepime Consumption Market Share by Type (2015-2020)
Table 50. Europe Cefepime Consumption by Application (2015-2020) (K Units)
Table 51. Europe Cefepime Consumption Market Share by Application (2015-2020)
Table 52. Middle East & Africa Cefepime Consumption by Countries (2015-2020) (K Units)
Table 53. Middle East & Africa Cefepime Consumption Market Share by Countries (2015-2020)
Table 54. Middle East & Africa Cefepime Value by Countries (2015-2020) ($ Millions)
Table 55. Middle East & Africa Cefepime Value Market Share by Countries (2015-2020)
Table 56. Middle East & Africa Cefepime Consumption by Type (2015-2020) (K Units)
Table 57. Middle East & Africa Cefepime Consumption Market Share by Type (2015-2020)
Table 58. Middle East & Africa Cefepime Consumption by Application (2015-2020) (K Units)
Table 59. Middle East & Africa Cefepime Consumption Market Share by Application (2015-2020)
Table 60. Cefepime Distributors List
Table 61. Cefepime Customer List
Table 62. Global Cefepime Consumption Forecast by Countries (2021-2025) (K Units)
Table 63. Global Cefepime Consumption Market Forecast by Regions
Table 64. Global Cefepime Value Forecast by Countries (2021-2025) ($ Millions)
Table 65. Global Cefepime Value Market Share Forecast by Regions
Table 66. Global Cefepime Consumption Forecast by Type (2021-2025) (K Units)
Table 67. Global Cefepime Consumption Market Share Forecast by Type (2021-2025)
Table 68. Global Cefepime Value Forecast by Type (2021-2025) ($ Millions)
Table 69. Global Cefepime Value Market Share Forecast by Type (2021-2025)
Table 70. Global Cefepime Consumption Forecast by Application (2021-2025) (K Units)
Table 71. Global Cefepime Consumption Market Share Forecast by Application (2021-2025)
Table 72. Global Cefepime Value Forecast by Application (2021-2025) ($ Millions)
Table 73. Global Cefepime Value Market Share Forecast by Application (2021-2025)
Table 74. Baxter Product Offered
Table 75. Baxter Cefepime Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 76. Baxter Main Business
Table 77. Baxter Latest Developments
Table 78. Baxter Basic Information, Company Total Revenue (in $ million), Cefepime Manufacturing Base, Sales Area and Its Competitors
Table 79. BMS Product Offered
Table 80. BMS Cefepime Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 81. BMS Main Business
Table 82. BMS Latest Developments
Table 83. BMS Basic Information, Company Total Revenue (in $ million), Cefepime Manufacturing Base, Sales Area and Its Competitors
Table 84. Apotex Product Offered
Table 85. Apotex Cefepime Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 86. Apotex Main Business
Table 87. Apotex Latest Developments
Table 88. Apotex Basic Information, Company Total Revenue (in $ million), Cefepime Manufacturing Base, Sales Area and Its Competitors
Table 89. Pfizer Product Offered
Table 90. Pfizer Cefepime Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 91. Pfizer Main Business
Table 92. Pfizer Latest Developments
Table 93. Pfizer Basic Information, Company Total Revenue (in $ million), Cefepime Manufacturing Base, Sales Area and Its Competitors
Table 94. Perrigo Product Offered
Table 95. Perrigo Cefepime Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 96. Perrigo Main Business
Table 97. Perrigo Latest Developments
Table 98. Perrigo Basic Information, Company Total Revenue (in $ million), Cefepime Manufacturing Base, Sales Area and Its Competitors
Table 99. B. Braun Medical Product Offered
Table 100. B. Braun Medical Cefepime Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 101. B. Braun Medical Main Business
Table 102. B. Braun Medical Latest Developments
Table 103. B. Braun Medical Basic Information, Company Total Revenue (in $ million), Cefepime Manufacturing Base, Sales Area and Its Competitors
Table 104. Piramal Critical Care Product Offered
Table 105. Piramal Critical Care Basic Information, Company Total Revenue (in $ million), Cefepime Manufacturing Base, Sales Area and Its Competitors
Table 106. Piramal Critical Care Main Business
Table 107. Piramal Critical Care Latest Developments
Table 108. Piramal Critical Care Cefepime Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 109. Fresenius Kabi Product Offered
Table 110. Fresenius Kabi Cefepime Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 111. Fresenius Kabi Main Business
Table 112. Fresenius Kabi Latest Developments
Table 113. Fresenius Kabi Basic Information, Company Total Revenue (in $ million), Cefepime Manufacturing Base, Sales Area and Its Competitors
Table 114. Meitheal Pharmaceuticals Product Offered
Table 115. Meitheal Pharmaceuticals Cefepime Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 116. Meitheal Pharmaceuticals Main Business
Table 117. Meitheal Pharmaceuticals Latest Developments
Table 118. Meitheal Pharmaceuticals Basic Information, Company Total Revenue (in $ million), Cefepime Manufacturing Base, Sales Area and Its Competitors
Table 119. Sandoz (Novartis) Product Offered
Table 120. Sandoz (Novartis) Cefepime Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 121. Sandoz (Novartis) Main Business
Table 122. Sandoz (Novartis) Latest Developments
Table 123. Sandoz (Novartis) Basic Information, Company Total Revenue (in $ million), Cefepime Manufacturing Base, Sales Area and Its Competitors
Table 124. Shandong Luoxin Pharmaceutical Group Product Offered
Table 125. Shandong Luoxin Pharmaceutical Group Cefepime Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 126. Shandong Luoxin Pharmaceutical Group Main Business
Table 127. Shandong Luoxin Pharmaceutical Group Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 128. Shandong Luoxin Pharmaceutical Group Latest Developments
Table 129. Yuekang Pharmaceutical Group Product Offered
Table 130. Yuekang Pharmaceutical Group Cefepime Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 131. Yuekang Pharmaceutical Group Main Business
Table 132. Yuekang Pharmaceutical Group Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 133. Yuekang Pharmaceutical Group Latest Developments
Table 134. Guangzhou Baiyunshan Tianxin Pharmaceutical Product Offered
Table 135. Guangzhou Baiyunshan Tianxin Pharmaceutical Cefepime Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 136. Guangzhou Baiyunshan Tianxin Pharmaceutical Main Business
Table 137. Guangzhou Baiyunshan Tianxin Pharmaceutical Latest Developments
Table 138. Guangzhou Baiyunshan Tianxin Pharmaceutical Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 139. Qilu Pharmaceutical Product Offered
Table 140. Qilu Pharmaceutical Cefepime Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 141. Qilu Pharmaceutical Main Business
Table 142. Qilu Pharmaceutical Latest Developments
Table 143. Qilu Pharmaceutical Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 144. Hebei Huamin Pharmaceutical Product Offered
Table 145. Hebei Huamin Pharmaceutical Cefepime Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 146. Hebei Huamin Pharmaceutical Main Business
Table 147. Hebei Huamin Pharmaceutical Latest Developments
Table 148. Hebei Huamin Pharmaceutical Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 149. Shanghai Xinfeng Pharmaceutical Product Offered
Table 150. Shanghai Xinfeng Pharmaceutical Cefepime Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 151. Shanghai Xinfeng Pharmaceutical Main Business
Table 152. Shanghai Xinfeng Pharmaceutical Latest Developments
Table 153. Shanghai Xinfeng Pharmaceutical Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 154. Jiangsu Hengrui Pharmaceutical Product Offered
Table 155. Jiangsu Hengrui Pharmaceutical Cefepime Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 156. Jiangsu Hengrui Pharmaceutical Main Business
Table 157. Jiangsu Hengrui Pharmaceutical Latest Developments
Table 158. Jiangsu Hengrui Pharmaceutical Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 159. Nanjing Haichen Pharmaceutical Product Offered
Table 160. Nanjing Haichen Pharmaceutical Cefepime Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 161. Nanjing Haichen Pharmaceutical Main Business
Table 162. Nanjing Haichen Pharmaceutical Latest Developments
Table 163. Nanjing Haichen Pharmaceutical Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 164. Sinopharm Product Offered
Table 165. Sinopharm Cefepime Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 166. Sinopharm Main Business
Table 167. Sinopharm Latest Developments
Table 168. Sinopharm Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 169. Chengdu Beite Pharmaceutical Product Offered
Table 170. Chengdu Beite Pharmaceutical Cefepime Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 171. Chengdu Beite Pharmaceutical Main Business
Table 172. Chengdu Beite Pharmaceutical Latest Developments
Table 173. Chengdu Beite Pharmaceutical Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 174. Suzhou Dongrui Pharmaceutical Product Offered
Table 175. Suzhou Dongrui Pharmaceutical Cefepime Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 176. Suzhou Dongrui Pharmaceutical Main Business
Table 177. Suzhou Dongrui Pharmaceutical Latest Developments
Table 178. Suzhou Dongrui Pharmaceutical Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 179. Hainan Hailing Pharmaceutical Product Offered
Table 180. Hainan Hailing Pharmaceutical Cefepime Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 181. Hainan Hailing Pharmaceutical Main Business
Table 182. Hainan Hailing Pharmaceutical Latest Developments
Table 183. Hainan Hailing Pharmaceutical Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 184. Shenzhen Xinlitai Pharmaceutical Product Offered
Table 185. Shenzhen Xinlitai Pharmaceutical Cefepime Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 186. Shenzhen Xinlitai Pharmaceutical Main Business
Table 187. Shenzhen Xinlitai Pharmaceutical Latest Developments
Table 188. Shenzhen Xinlitai Pharmaceutical Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 189. Hainan Star Pharmaceutical Product Offered
Table 190. Hainan Star Pharmaceutical Cefepime Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 191. Hainan Star Pharmaceutical Main Business
Table 192. Hainan Star Pharmaceutical Latest Developments
Table 193. Hainan Star Pharmaceutical Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 194. Shenzhen Lijian Pharmaceutical Product Offered
Table 195. Shenzhen Lijian Pharmaceutical Cefepime Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 196. Shenzhen Lijian Pharmaceutical Main Business
Table 197. Shenzhen Lijian Pharmaceutical Latest Developments
Table 198. Shenzhen Lijian Pharmaceutical Basic Information, Manufacturing Base, Sales Area and Its Competitors
List of Figures
Figure 1. Picture of Cefepime
Figure 2. Cefepime Report Years Considered
Figure 3. Market Research Methodology
Figure 4. Global Cefepime Consumption Growth Rate 2015-2025 (K Units)
Figure 5. Global Cefepime Value Growth Rate 2015-2025 ($ Millions)
Figure 6. Product Picture of Intramuscular Injection
Figure 7. Product Picture of Intravenous Drug Delivery
Figure 8. Global Cefepime Consumption Market Share by Type (2015-2020)
Figure 9. Global Cefepime Value Market Share by Type (2015-2020)
Figure 10. Cefepime Consumed in Lower Respiratory Tract Infection
Figure 11. Global Cefepime Market: Lower Respiratory Tract Infection (2015-2020) (K Units)
Figure 12. Global Cefepime Market: Lower Respiratory Tract Infection (2015-2020) ($ Millions)
Figure 13. Cefepime Consumed in Urinary Tract Infection
Figure 14. Global Cefepime Market: Urinary Tract Infection (2015-2020) (K Units)
Figure 15. Global Cefepime Market: Urinary Tract Infection (2015-2020) ($ Millions)
Figure 16. Cefepime Consumed in Skin And Soft Tissue Infections
Figure 17. Global Cefepime Market: Skin And Soft Tissue Infections (2015-2020) (K Units)
Figure 18. Global Cefepime Market: Skin And Soft Tissue Infections (2015-2020) ($ Millions)
Figure 19. Cefepime Consumed in Abdominal Cavity Infection
Figure 20. Global Cefepime Market: Abdominal Cavity Infection (2015-2020) (K Units)
Figure 21. Global Cefepime Market: Abdominal Cavity Infection (2015-2020) ($ Millions)
Figure 22. Cefepime Consumed in Gynecologic Infection
Figure 23. Global Cefepime Market: Gynecologic Infection (2015-2020) (K Units)
Figure 24. Global Cefepime Market: Gynecologic Infection (2015-2020) ($ Millions)
Figure 25. Cefepime Consumed in Sepsis
Figure 26. Cefepime Consumed in Neutrophilic Fever
Figure 27. Global Cefepime Consumption Market Share by Application (2015-2020)
Figure 28. Global Cefepime Value Market Share by Application (2015-2020)
Figure 29. Global Cefepime Sales Market Share by Company in 2017
Figure 30. Global Cefepime Sales Market Share by Company in 2019
Figure 31. Global Cefepime Revenue Market Share by Company in 2017
Figure 32. Global Cefepime Revenue Market Share by Company in 2019
Figure 33. Global Cefepime Sale Price by Company in 2019
Figure 34. Global Cefepime Consumption Market Share by Regions 2015-2020
Figure 35. Global Cefepime Value Market Share by Regions 2015-2020
Figure 36. Americas Cefepime Consumption 2015-2020 (K Units)
Figure 37. Americas Cefepime Value 2015-2020 ($ Millions)
Figure 38. APAC Cefepime Consumption 2015-2020 (K Units)
Figure 39. APAC Cefepime Value 2015-2020 ($ Millions)
Figure 40. Europe Cefepime Consumption 2015-2020 (K Units)
Figure 41. Europe Cefepime Value 2015-2020 ($ Millions)
Figure 42. Middle East & Africa Cefepime Consumption 2015-2020 (K Units)
Figure 43. Middle East & Africa Cefepime Value 2015-2020 ($ Millions)
Figure 44. Americas Cefepime Consumption Market Share by Countries in 2019
Figure 45. Americas Cefepime Value Market Share by Countries in 2019
Figure 46. Americas Cefepime Consumption Market Share by Type in 2019
Figure 47. Americas Cefepime Consumption Market Share by Application in 2019
Figure 48. United States Cefepime Consumption Growth 2015-2020 (K Units)
Figure 49. United States Cefepime Value Growth 2015-2020 ($ Millions)
Figure 50. Canada Cefepime Consumption Growth 2015-2020 (K Units)
Figure 51. Canada Cefepime Value Growth 2015-2020 ($ Millions)
Figure 52. Mexico Cefepime Consumption Growth 2015-2020 (K Units)
Figure 53. Mexico Cefepime Value Growth 2015-2020 ($ Millions)
Figure 54. APAC Cefepime Consumption Market Share by Countries in 2019
Figure 55. APAC Cefepime Value Market Share by Regions in 2019
Figure 56. APAC Cefepime Consumption Market Share by Type in 2019
Figure 57. APAC Cefepime Consumption Market Share by Application in 2019
Figure 58. China Cefepime Consumption Growth 2015-2020 (K Units)
Figure 59. China Cefepime Value Growth 2015-2020 ($ Millions)
Figure 60. Japan Cefepime Consumption Growth 2015-2020 (K Units)
Figure 61. Japan Cefepime Value Growth 2015-2020 ($ Millions)
Figure 62. Korea Cefepime Consumption Growth 2015-2020 (K Units)
Figure 63. Korea Cefepime Value Growth 2015-2020 ($ Millions)
Figure 64. Southeast Asia Cefepime Consumption Growth 2015-2020 (K Units)
Figure 65. Southeast Asia Cefepime Value Growth 2015-2020 ($ Millions)
Figure 66. India Cefepime Consumption Growth 2015-2020 (K Units)
Figure 67. India Cefepime Value Growth 2015-2020 ($ Millions)
Figure 68. Australia Cefepime Consumption Growth 2015-2020 (K Units)
Figure 69. Australia Cefepime Value Growth 2015-2020 ($ Millions)
Figure 70. Europe Cefepime Consumption Market Share by Countries in 2019
Figure 71. Europe Cefepime Value Market Share by Countries in 2019
Figure 72. Europe Cefepime Consumption Market Share by Type in 2019
Figure 73. Europe Cefepime Consumption Market Share by Application in 2019
Figure 74. Germany Cefepime Consumption Growth 2015-2020 (K Units)
Figure 75. Germany Cefepime Value Growth 2015-2020 ($ Millions)
Figure 76. France Cefepime Consumption Growth 2015-2020 (K Units)
Figure 77. France Cefepime Value Growth 2015-2020 ($ Millions)
Figure 78. UK Cefepime Consumption Growth 2015-2020 (K Units)
Figure 79. UK Cefepime Value Growth 2015-2020 ($ Millions)
Figure 80. Italy Cefepime Consumption Growth 2015-2020 (K Units)
Figure 81. Italy Cefepime Value Growth 2015-2020 ($ Millions)
Figure 82. Russia Cefepime Consumption Growth 2015-2020 (K Units)
Figure 83. Russia Cefepime Value Growth 2015-2020 ($ Millions)
Figure 84. Middle East & Africa Cefepime Consumption Market Share by Countries in 2019
Figure 85. Middle East & Africa Cefepime Value Market Share by Countries in 2019
Figure 86. Middle East & Africa Cefepime Consumption Market Share by Type in 2019
Figure 87. Middle East & Africa Cefepime Consumption Market Share by Application in 2019
Figure 88. Egypt Cefepime Consumption Growth 2015-2020 (K Units)
Figure 89. Egypt Cefepime Value Growth 2015-2020 ($ Millions)
Figure 90. South Africa Cefepime Consumption Growth 2015-2020 (K Units)
Figure 91. South Africa Cefepime Value Growth 2015-2020 ($ Millions)
Figure 92. Israel Cefepime Consumption Growth 2015-2020 (K Units)
Figure 93. Israel Cefepime Value Growth 2015-2020 ($ Millions)
Figure 94. Turkey Cefepime Consumption Growth 2015-2020 (K Units)
Figure 95. Turkey Cefepime Value Growth 2015-2020 ($ Millions)
Figure 96. GCC Countries Cefepime Consumption Growth 2015-2020 (K Units)
Figure 97. GCC Countries Cefepime Value Growth 2015-2020 ($ Millions)
Figure 98. Global Cefepime Consumption Growth Rate Forecast (2021-2025) (K Units)
Figure 99. Global Cefepime Value Growth Rate Forecast (2021-2025) ($ Millions)
Figure 100. Americas Cefepime Consumption 2021-2025 (K Units)
Figure 101. Americas Cefepime Value 2021-2025 ($ Millions)
Figure 102. APAC Cefepime Consumption 2021-2025 (K Units)
Figure 103. APAC Cefepime Value 2021-2025 ($ Millions)
Figure 104. Europe Cefepime Consumption 2021-2025 (K Units)
Figure 105. Europe Cefepime Value 2021-2025 ($ Millions)
Figure 106. Middle East & Africa Cefepime Consumption 2021-2025 (K Units)
Figure 107. Middle East & Africa Cefepime Value 2021-2025 ($ Millions)
Figure 108. United States Cefepime Consumption 2021-2025 (K Units)
Figure 109. United States Cefepime Value 2021-2025 ($ Millions)
Figure 110. Canada Cefepime Consumption 2021-2025 (K Units)
Figure 111. Canada Cefepime Value 2021-2025 ($ Millions)
Figure 112. Mexico Cefepime Consumption 2021-2025 (K Units)
Figure 113. Mexico Cefepime Value 2021-2025 ($ Millions)
Figure 114. Brazil Cefepime Consumption 2021-2025 (K Units)
Figure 115. Brazil Cefepime Value 2021-2025 ($ Millions)
Figure 116. China Cefepime Consumption 2021-2025 (K Units)
Figure 117. China Cefepime Value 2021-2025 ($ Millions)
Figure 118. Japan Cefepime Consumption 2021-2025 (K Units)
Figure 119. Japan Cefepime Value 2021-2025 ($ Millions)
Figure 120. Korea Cefepime Consumption 2021-2025 (K Units)
Figure 121. Korea Cefepime Value 2021-2025 ($ Millions)
Figure 122. Southeast Asia Cefepime Consumption 2021-2025 (K Units)
Figure 123. Southeast Asia Cefepime Value 2021-2025 ($ Millions)
Figure 124. India Cefepime Consumption 2021-2025 (K Units)
Figure 125. India Cefepime Value 2021-2025 ($ Millions)
Figure 126. Australia Cefepime Consumption 2021-2025 (K Units)
Figure 127. Australia Cefepime Value 2021-2025 ($ Millions)
Figure 128. Germany Cefepime Consumption 2021-2025 (K Units)
Figure 129. Germany Cefepime Value 2021-2025 ($ Millions)
Figure 130. France Cefepime Consumption 2021-2025 (K Units)
Figure 131. France Cefepime Value 2021-2025 ($ Millions)
Figure 132. UK Cefepime Consumption 2021-2025 (K Units)
Figure 133. UK Cefepime Value 2021-2025 ($ Millions)
Figure 134. Italy Cefepime Consumption 2021-2025 (K Units)
Figure 135. Italy Cefepime Value 2021-2025 ($ Millions)
Figure 136. Russia Cefepime Consumption 2021-2025 (K Units)
Figure 137. Russia Cefepime Value 2021-2025 ($ Millions)
Figure 138. Spain Cefepime Consumption 2021-2025 (K Units)
Figure 139. Spain Cefepime Value 2021-2025 ($ Millions)
Figure 140. Egypt Cefepime Consumption 2021-2025 (K Units)
Figure 141. Egypt Cefepime Value 2021-2025 ($ Millions)
Figure 142. South Africa Cefepime Consumption 2021-2025 (K Units)
Figure 143. South Africa Cefepime Value 2021-2025 ($ Millions)
Figure 144. Israel Cefepime Consumption 2021-2025 (K Units)
Figure 145. Israel Cefepime Value 2021-2025 ($ Millions)
Figure 146. Turkey Cefepime Consumption 2021-2025 (K Units)
Figure 147. Turkey Cefepime Value 2021-2025 ($ Millions)
Figure 148. GCC Countries Cefepime Consumption 2021-2025 (K Units)
Figure 149. GCC Countries Cefepime Value 2021-2025 ($ Millions)
Figure 150. Baxter Cefepime Market Share (2018-2020)
Figure 151. BMS Cefepime Market Share (2018-2020)
Figure 152. Apotex Cefepime Market Share (2018-2020)
Figure 153. Pfizer Cefepime Market Share (2018-2020)
Figure 154. Perrigo Cefepime Market Share (2018-2020)
Figure 155. B. Braun Medical Cefepime Market Share (2018-2020)
Figure 156. Piramal Critical Care Cefepime Market Share (2018-2020)
Figure 157. Fresenius Kabi Cefepime Market Share (2018-2020)
Figure 158. Meitheal Pharmaceuticals Cefepime Market Share (2018-2020)
Figure 159. Sandoz (Novartis) Cefepime Market Share (2018-2020)
Figure 160. Shandong Luoxin Pharmaceutical Group Cefepime Market Share (2018-2020)
Figure 161. Yuekang Pharmaceutical Group Cefepime Market Share (2018-2020)
Figure 162. Guangzhou Baiyunshan Tianxin Pharmaceutical Cefepime Market Share (2018-2020)
Figure 163. Qilu Pharmaceutical Cefepime Market Share (2018-2020)
Figure 164. Hebei Huamin Pharmaceutical Cefepime Market Share (2018-2020)
Figure 165. Shanghai Xinfeng Pharmaceutical Cefepime Market Share (2018-2020)
Figure 166. Jiangsu Hengrui Pharmaceutical Cefepime Market Share (2018-2020)
Figure 167. Nanjing Haichen Pharmaceutical Cefepime Market Share (2018-2020)
Figure 168. Sinopharm Cefepime Market Share (2018-2020)
Figure 169. Chengdu Beite Pharmaceutical Cefepime Market Share (2018-2020)
Figure 170. Suzhou Dongrui Pharmaceutical Cefepime Market Share (2018-2020)
Figure 171. Hainan Hailing Pharmaceutical Cefepime Market Share (2018-2020)
Figure 172. Shenzhen Xinlitai Pharmaceutical Cefepime Market Share (2018-2020)
Figure 173. Hainan Star Pharmaceutical Cefepime Market Share (2018-2020)
Figure 174. Shenzhen Lijian Pharmaceutical Cefepime Market Share (2018-2020)
